Zobrazeno 1 - 10
of 11 613
pro vyhledávání: '"aldosteronism"'
Autor:
Yuki Taki, Takashi Kono, Kyoko Teruyama, Takamasa Ichijo, Ikki Sakuma, Hidekazu Nagano, Hiroka Miyagawa, Satomi Kono, Masanori Fujimoto, Naoko Hashimoto, Masataka Yokoyama, Eiryo Kawakami, Takashi Miki, Tomoaki Tanaka
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-14 (2024)
Abstract The transition from radioimmunoassay (RIA) to chemiluminescent enzyme immunoassay (CLEIA) for plasma aldosterone concentration (PAC) assays has raised concerns over its impact on primary aldosteronism (PA) diagnosis. This study investigated
Externí odkaz:
https://doaj.org/article/00cc61d5324c43ca90c6c2c166d3c387
Autor:
Chu-Wen Fang, Hui-Lung Hsieh, Shuo-Meng Wang, Kuo-How Huang, Kang-Yung Peng, Yen-Hung Lin, Vin-Cent Wu, Jeff S. Chueh
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Primary aldosteronism (PA), which is present in 5–18% of hypertensive patients, is a leading cause of secondary hypertension. Adrenalectomy is often recommended for patients with unilateral primary aldosteronism (uPA), yielding
Externí odkaz:
https://doaj.org/article/d5b86ea7c9c349c098f7c959c6a641fd
Autor:
Jianjuan Sun, Qiurong Zeng, Longbing Lai, Mingjun Gu, Dingrong Liu, Guangxiu Wu, Chuan Peng, Shuming Yang, Qifu Li, Jiangang Lu
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-8 (2024)
Abstract Background Primary aldosteronism is characterized by high plasma aldosterone and low renin. The plasma aldosterone-to-renin ratio is recommended for screening. Severe hydronephrosis leads to renal parenchymal ischemia, resulting in increased
Externí odkaz:
https://doaj.org/article/f68f25f5c1d54805bf235dd21e335711
Publikováno v:
The Journal of Clinical Hypertension, Vol 26, Iss 9, Pp 1116-1120 (2024)
Abstract The authors report a case of primary aldosteronism (PA) with postoperative elevation of aldosterone treated effectively by finerenone. The patient was a hypertensive man with a 30‐year history of hypertension and sustained an acute myocard
Externí odkaz:
https://doaj.org/article/07018f3809254764940c5bba22d8894f
Autor:
Zhe Hu, Xin Chen, Yi‐Bang Cheng, Ping Zhong, Qing‐An Li, Yu Zhao, Hong Luan, Jie Ren, Gai‐Ling Chen, Ji‐Guang Wang
Publikováno v:
The Journal of Clinical Hypertension, Vol 26, Iss 9, Pp 1082-1089 (2024)
Abstract We investigated the clinical characteristics of primary aldosteronism (PA) screened from patients with hypertension in China. The participants were hypertensive patients who were suspected of PA and registered in the China Primary Aldosteron
Externí odkaz:
https://doaj.org/article/e20aa46a01344dd4b193bd34270a7566
Autor:
Sandra Karanović Štambuk
Publikováno v:
Kidney & Blood Pressure Research, Vol 49, Iss 1, Pp 839-842 (2024)
Introduction: Primary aldosteronism (PA), a common secondary cause of arterial hypertension, is treated either surgically or pharmacologically with mineralocorticoid receptor antagonists (MRAs). These drugs, while effective, can cause allergic reacti
Externí odkaz:
https://doaj.org/article/4f09727ec6de43649b01a3c2a1d9ab7a
Autor:
Min Mao, Rui Feng, Nouman Ali Khan, Li Tao, Ping Tang, Yongpeng Zhao, Jie Chen, Xin Li, Hong Zhao, Qiuyue Shi, Ling Wang, Fengjie Lyu, Muhammad Arif Asghar, Yutian He, Jing Chang, Rui Xiang
Publikováno v:
BMC Surgery, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Objective This study aimed to assess the efficacy and safety of bilateral superselective adrenal arterial embolization (SAAE) in patients with bilateral idiopathic hyperaldosteronism (IHA), a subtype of PA. Methods Ninety-eight patients with
Externí odkaz:
https://doaj.org/article/95cdbff8277a451098f46b50913e4626